Institutional Council Chair:
Julian Shepelev, MSc, MASc, BSc
Market Access, HEOR, EMEA, Baxter Healthcare
London, LON, United Kingdom
Institutional Council Chair Elect:
Christopher M. Blanchette, PhD
Vice President, Novo Nordisk
Doylestown, PA, United States
Institutional Council Past Chairs:
2023-2024 Chair:
Peter Wirth
Vice President, Business Development, RTI Health Solutions
Durham, NC, USA
2022-2023 Chair:
Hemant Phatak
Head, Global Health Economics and Outcomes Research, Amylyx Pharmaceuticals
Cambridge, MA, USA
2021-2022 Chair:
Ami Buikema
Principal Consultant, Vice President, HEOR, Optum
Eden Prairie, MN, USA
2020-2021 Chair:
Bill Marder
Chief Data Strategist, IBM Watson Health
Cambridge, MA, USA
2019 Chair:
David Van Brunt
Senior Director, Global HEOR, AbbVie
Chicago, IL, USA
2018 Chair:
Pamela Blumberg, MPH, DrPH
Lead, Real-world Evidence Strategy, TriNetX
Fort Mill, SC, USA
2017 Chair:
Mark Cziraky, PharmD
Vice President, Research, HealthCore, Inc.
Wilmington, DE, USA
2016 Chair:
James Murray, PhD
Research Fellow, Global Health Outcomes and COE, Eli Lilly and Co.
Carmel, IN, USA
2015 Chair:
Sheldon Kong, PhD
Executive Director, Health Economics and Outcomes Research
Novo Nordisk Inc.
Plainsboro, NJ, USA
2014 Chair:
Donald Yin, PhD
Vice President
Merck
Upper Gwynedd, PA, USA
2013 Chair:
John O'Donnell, PhD
Vice President, Global Health Outcomes
Bristol-Myers Squibb Co.
Princeton, NJ, USA
2012 Past Chair:
Phillip Sarocco, RPh, MSc
Head, Health Economics & Outcomes Research,
IRONWOOD Pharmaceuticals
Cambridge, MA, USA